{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:23:29Z","timestamp":1780320209949,"version":"3.54.1"},"reference-count":53,"publisher":"BMJ","issue":"21","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2018,5,17]]},"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>Regional myocardial ischaemia is commonly expressed as exertional angina in patients with stable coronary artery disease (CAD). It also associates with prognosis, risk tending to increase with the severity of ischaemia. The validity of myocardial ischaemia as a surrogate for adverse clinical outcomes, however, has not been well established. Thus, in cohort studies, ischaemia testing has failed to influence rates of myocardial infarction and coronary death. Moreover, in clinical studies, pharmacological and interventional treatments that are effective in correcting ischaemia have rarely been shown to reduce cardiovascular (CV) risk. This contrasts with statins and other anti-inflammatory drugs that have no direct effect on ischaemia but improve CV outcomes by modifying the atherothrombotic disease process. Despite this, and with little evidence of patient benefit, stress testing is commonly used during the follow-up of patients with stable CAD when the demonstration of ischaemic change may be seen as a target for treatment, independently of symptomatic status. Substitution of a symptom-driven management strategy has the potential to reduce rates of non-invasive stress testing, unnecessary downstream revascularisation procedures and use of valuable resources in patients with stable CAD without adverse consequences for CV risk.<\/jats:p>","DOI":"10.1136\/heartjnl-2018-313230","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T12:20:53Z","timestamp":1528287653000},"page":"1733-1738","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Validity of inducible ischaemia as a surrogate for adverse outcomes in stable coronary artery disease"],"prefix":"10.1136","volume":"104","author":[{"given":"Adam","family":"Timmis","sequence":"first","affiliation":[{"name":"Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK"},{"name":"Department of Interventional Cardiology, Barts Heart Centre, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Raharja","sequence":"additional","affiliation":[{"name":"Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Archbold","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, Barts Heart Centre, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Mathur","sequence":"additional","affiliation":[{"name":"Barts and The London School of Medicine and Dentistry, Queen Mary University London, London, UK"},{"name":"Department of Interventional Cardiology, Barts Heart Centre, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,6,6]]},"reference":[{"key":"2025092001150397000_104.21.1733.1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1991.00400120019004"},{"key":"2025092001150397000_104.21.1733.2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ehjqcco\/qcw010","article-title":"Persisting chest pain in nonobstructive coronary artery disease","volume":"2","author":"Bugiardini","year":"2016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025092001150397000_104.21.1733.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342604"},{"key":"2025092001150397000_104.21.1733.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.035"},{"key":"2025092001150397000_104.21.1733.5","unstructured":"NICE Medical technologies guidance [MTG32]. HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography. 2017 https:\/\/www.nice.org.uk\/guidance\/mtg32."},{"key":"2025092001150397000_104.21.1733.6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht296"},{"key":"2025092001150397000_104.21.1733.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.07.013"},{"key":"2025092001150397000_104.21.1733.8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005285"},{"key":"2025092001150397000_104.21.1733.9","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5403"},{"key":"2025092001150397000_104.21.1733.10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv164"},{"key":"2025092001150397000_104.21.1733.11","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.6.535"},{"key":"2025092001150397000_104.21.1733.12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12350-011-9475-8","article-title":"Severity of inducible myocardial ischemia predicts incident acute coronary syndromes in asymptomatic individuals with a family history of premature coronary artery disease","volume":"19","author":"Kral","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"2025092001150397000_104.21.1733.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.03.080"},{"key":"2025092001150397000_104.21.1733.14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2016.09.006","article-title":"Causes and predictors of death in patients with coronary heart disease (from the heart and soul study)","volume":"119","author":"Wang","year":"2017","journal-title":"Am J Cardiol"},{"key":"2025092001150397000_104.21.1733.15","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jamainternmed.2014.3773","article-title":"Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry","volume":"174","author":"Steg","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025092001150397000_104.21.1733.16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/14.4.484"},{"key":"2025092001150397000_104.21.1733.17","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1002\/clc.20513","article-title":"Preinfarction angina prior to first myocardial infarction does not influence long-term prognosis: a retrospective study with subgroup analysis in elderly and diabetic patients","volume":"32","author":"Jim\u00e9nez-Navarro","year":"2009","journal-title":"Clin Cardiol"},{"key":"2025092001150397000_104.21.1733.18","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.090894"},{"key":"2025092001150397000_104.21.1733.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02834-6"},{"key":"2025092001150397000_104.21.1733.20","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.3.657"},{"key":"2025092001150397000_104.21.1733.21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs411"},{"key":"2025092001150397000_104.21.1733.22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jamacardio.2016.0263","article-title":"Association of coronary stenosis and plaque morphology with fractional flow reserve and outcomes","volume":"1","author":"Ahmadi","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2025092001150397000_104.21.1733.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.093"},{"key":"2025092001150397000_104.21.1733.24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamainternmed.2013.14407","article-title":"Hospital variation in the use of noninvasive cardiac imaging and its association with downstream testing, interventions, and outcomes","volume":"174","author":"Safavi","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025092001150397000_104.21.1733.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406430"},{"key":"2025092001150397000_104.21.1733.26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.12559"},{"key":"2025092001150397000_104.21.1733.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070829"},{"key":"2025092001150397000_104.21.1733.28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.743963"},{"key":"2025092001150397000_104.21.1733.29","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-012-9548-3"},{"key":"2025092001150397000_104.21.1733.30","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000072790.23090.41"},{"key":"2025092001150397000_104.21.1733.31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ehjqcco\/qcv017","article-title":"Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization","volume":"2","author":"Elbez","year":"2016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025092001150397000_104.21.1733.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.043"},{"key":"2025092001150397000_104.21.1733.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91963-1"},{"key":"2025092001150397000_104.21.1733.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602001"},{"key":"2025092001150397000_104.21.1733.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.014"},{"key":"2025092001150397000_104.21.1733.36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjqcco\/qcv026","article-title":"Prognostic impact of percutaneous coronary intervention in stable coronary disease","volume":"2","author":"de Belder","year":"2016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025092001150397000_104.21.1733.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211585"},{"key":"2025092001150397000_104.21.1733.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804626"},{"key":"2025092001150397000_104.21.1733.39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ehjqcco\/qcw007","article-title":"A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era","volume":"2","author":"Ariyaratne","year":"2016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025092001150397000_104.21.1733.40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.031907"},{"key":"2025092001150397000_104.21.1733.41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","article-title":"Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025092001150397000_104.21.1733.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"2025092001150397000_104.21.1733.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914"},{"key":"2025092001150397000_104.21.1733.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32714-9"},{"key":"2025092001150397000_104.21.1733.45","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-157-8-201210160-00535"},{"key":"2025092001150397000_104.21.1733.46","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0296"},{"key":"2025092001150397000_104.21.1733.47","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308341"},{"key":"2025092001150397000_104.21.1733.48","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2017-311508"},{"key":"2025092001150397000_104.21.1733.49","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jet232"},{"key":"2025092001150397000_104.21.1733.50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ehjqcco\/qcw003","article-title":"Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER)","volume":"2","author":"Walker","year":"2016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025092001150397000_104.21.1733.51","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)07391-2"},{"key":"2025092001150397000_104.21.1733.52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4379"},{"key":"2025092001150397000_104.21.1733.53","unstructured":"Shaw LJ , Phillips LM , Picard MH , et al . An Update on the ISCHEMIA Trial. 2017. http:\/\/www.acc.org\/latest-in-cardiology\/articles\/2017\/07\/25\/14\/30\/an-update-on-the-ischemia-trial"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2018-313230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:15:14Z","timestamp":1758356114000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2018-313230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,6]]},"references-count":53,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2018,10,11]]},"published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1136\/heartjnl-2018-313230"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2018-313230","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,6]]}}}